Roche Secures Dicerna RNAi Deal For Hepatitis B

Roche Pays $200m Up Front For DCR-HBVS Candidate

 
• By Alexandra Shimmings
Hepatitis B
Hepatitis B Virus • Source: Shutterstock

More from Business

More from Scrip